Who owns Lyra Therapeutics, Inc.? Owners, funding and legal record

Before you sign or pay

• Court and bankruptcy: No federal court case or bankruptcy filing found under Lyra Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
• Layoffs: 1 exit or restructuring plan reported on Form 8-K, Item 2.05 (latest filed 2026-01-12).
• Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Sabby Management, LLC (filed 2026-01-20).

Who is behind it

Lyra Therapeutics, Inc.: incorporated in Delaware; business address in Watertown, Massachusetts; industry Surgical & Medical Instruments & Apparatus (Schedule 13G, 2026-01-20).

Officers and directors, each with the role and the filing that names them:

• Harlan Waksal, M.D.: Executive Officer, Director (Form D, 2023-06-09)
• Maria Palasis, Ph.D.: Executive Officer, Director (Form D, 2023-06-09)
• Jason Cavalier: Executive Officer (Form D, 2023-06-09)
• Michael Altman: Director (Form D, 2023-06-09)
• Edward Anderson: Director (Form D, 2023-06-09)
• C. Ann Merrifield: Director (Form D, 2023-06-09)
• Konstantin Poukalov: Director (Form D, 2023-06-09)
• W. Bradford Smith: Director (Form D, 2023-06-09)
• Nancy Snyderman, M.D., FACS: Director (Form D, 2023-06-09)
• James R. Tobin: Director (Form D, 2023-06-09)
• John Bishop, Ph.D.: Executive Officer (Form D, 2023-06-09)
• Richard Nieman, M.D.: Executive Officer (Form D, 2023-06-09)

Money raised

Latest IPO step: Lyra Therapeutics, Inc. filed to go public (S-1, 2025-07-22).

IPO filings: S-1, 2025-07-22.

Red flags found

1 exit or restructuring plan on Form 8-K (latest Form 8-K, 2026-01-12).

Related pages

Layoffs5%+ holders

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

All companies

Not for employment, credit, insurance or tenancy decisions.